Cyclic nucleotide phosphodiesterases
US6080548A · kind A · utility
2Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 23, 1999 |
| Grant date | Jun 27, 2000 |
| Priority date | — |
| Expiry date | Feb 23, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N9/16
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention provides human cyclic nucleotide phosphodiesterases (PDE8) and polynucleotides which identify and encode PDE8. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of PDE8.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.